C2N Diagnostics expands UK partnership to improve Alzheimer’s diagnosis
On World Alzheimer’s Day, C2N Diagnostics announced a UK partnership with Cambridge Cognition and The Alzheimer’s Trust to create an integrated diagnostic pathway combining C2N’s MHRA-registered PrecivityAD2 blood test, Cambridge Cognition’s CANTAB Pathway digital cognitive assessments and The Alzhe
<p>On World Alzheimer’s Day, C2N Diagnostics announced a UK partnership with Cambridge Cognition and The Alzheimer’s Trust to create an integrated diagnostic pathway combining C2N’s MHRA-registered PrecivityAD2 blood test, Cambridge Cognition’s CANTAB Pathway digital cognitive assessments and The Alzhe</p>